187 results about "Menstrual cycle" patented technology

Provided are methods and kits for administering progestogen as a glucocorticoid sensitizer to restore corticosteroid sensitivity or reverse the glucocorticoid insensitivity or enhance glucocorticoid sensitivity, in order to treat one or more glucocorticoid insensitivity related diseases or conditions. For example, these include methods for reversing the glucocorticoid insensitivity in a subject having no history of menstrual cycle-related exacerbation or allergy to self-hormones, particularly progesterone, such as premenstrual or perimenstrual deterioration in the symptoms, e.g., premenstrual worsening of atopic dermatitis or premenstrual exacerbations of asthma, and exhibiting relatively or totally refractory responses to glucocorticoid therapy, e.g., glucocorticoid resistance. The methods and kits provide for the administration of a sex hormone to the subject who is corticosteroid dependent or corticoid resistant or unresponsive or intolerant to corticosteroids.

A portable electronic device for reducing periodic cramping about an abdominal cavity of a user during a menstrual cycle includes an elastic panty garment, a controller removably attached directly to an outer surface of the panty garment and a plurality of electro-mechanical transducers generating output vibrations, and a plurality of heatable magnetic straps directly coupled to the outer surface of the panty garment. The heatable magnetic straps extend along anterior and posterior faces of the panty garment and are simultaneously actuated to a desired temperature level while the transducers are actuated to an on position. The heatable magnetic straps being freely movable along the outer surface of the panty garment while the transducers are nested within respective pouches.

The present invention relates to a hormonal contraceptive product having two hormonal components, an estrogen and a gestagen, and a method for the continuous suppression of the menstrual cycle by uninterrupted administration of the product of the invention.

A method for preventing or treating a catamenial migrainous disorder in a female subject comprises administering to a vulvovaginal surface of the subject a pharmaceutical composition that is bioadhesive thereto and comprises at least one estrogenic compound in an amount of about 50 μg to about 1000 μg estradiol equivalent per unit dose of the composition. A related method comprises administering to a vulvovaginal surface of the subject a pharmaceutical composition comprising at least one estrogenic compound, wherein upon administration of the composition to the vulvovaginal surface, a decline in serum estradiol concentration during a luteal phase of a menstrual cycle is moderated.

The invention provides a method for providing contraception in a woman, wherein the woman is administered with a progestogen-only contraception composition once-a-month between the 1^st and the 10^th day of the woman menstrual cycle. It is further provided a system for reminding a woman of taking such contraceptive composition.

A single axis rotatable disc calendar for calculating time periods and future dates based on current or past events is disclosed. In particular, calculators for determining fertility timing, testing and treatment dates have a base circular calendar (61) and one or more discs (58, 59, 60) containing information about menstrual cycles and ovulation events. The base circular calendar has 365 divisions (67) for the days in the year or 153 divisions for a shortened calendar excluding February. A separate February calendar with a leap February month is provided on the back of the base.

Devices and systems for facilitating the flow of menses through the cervix and for shortening the duration of menstruation include a pressure oscillations generating unit insertable into a vagina and configured for delivering pressure oscillations and/or acoustic waves and/or shock waves to the vagina and cervix to change the flow properties of menses fluid. The pressure oscillations generating unit may include one or more vibratable or movable members for generating pressure oscillations which may be powered by an internal or external power source. The devices may optionally include an absorbing member or a menses collecting member. A method of menstruation duration shortening includes placing the device within the vagina and applying pressure oscillations to the vagina or to a vaginal chamber formed within the vagina for increasing the flow rate of menses and shortening menstruation duration.

The present invention provides a method for determining the gender of an unborn child by assaying the overall reducing/oxidizing or redox activity of the maternal urine or other body fluid. The method can be used to determine fetal gender at any time point during the entire pregnancy, the earliest being the first day of a missed menstruation. The body fluid may be processed before assaying. Processing may involve aging the body fluid, or purification of various fractions. The methods of the present invention also provide for a means for pre-conception baby gender planning by assaying the overall redox activity of a non-pregnant female's urine or other body fluid. The overall redox activity of a urine sample correlates with the gender specific compatibility of the ovum being released during a particular menstrual cycle. Therefore, assaying the overall redox activity of a non-pregnant female's urine will help a couple conceive a baby having a desired gender.

The invention discloses a novel Chinese medicinal composition for treating delayed menstrual cycle and a preparation method thereof. The Chinese medicinal composition mainly comprises the following raw material medicaments: root of red-rooted salvia, szechuan lovage rhizome, safflower, peach seed, roasted pangolin scales, motherwort herb, medlar, tuber fleeceflower root, white paeony root, pilose asiabell root, raw astragalus, cinnamomvine, Chinese angelica, roasted frankincense, roasted myrrh, cassia bark, cassia twig, dried ginger, medcinal evodia fruit, tangerine peel, green tangerine peel, immature bitter orange, cyperusrotundus, szechwan chinaberry fruit, rhizoma corydalis, radix curcumae, suberect spatholobus stem, cowherb seed, radix rehmanniae preparata, donkey-hide glue and the like. The Chinese medicinal composition can be prepared into any one common orally-taken preparation by a conventional Chinese medicinal preparation method. The Chinese medicinal composition can remarkably improve the symptoms: delayed menstrual cycle, delayed menstruation, delayed menstrual cycle, scant menstrual flow, lumpy menses with dark color, lesser abdomen, distention and pain of the breast, depression, lusterless complexion, fatigue and lack of strength and other symptoms, and has the advantages of extract clinical treatment effect, remarkable treatment effect, quick response, basically no toxic or side effect and the like.

The invention discloses a women's ovulation detecting system and method. The women's ovulation detecting system comprises an input module, a menstrual period management module and an ovulation detecting module, a client side inputs the date, time and period of current menstruation into the ovulation detecting system through the input module, the menstrual period management module is connected with the input module and stores and manages data of the date, the time and the period of current menstruation, and the ovulation detecting module is connected with the menstrual period management module and detects the ovulation result according to the ovulation sample comparison result and the data of the menstrual period management module.

A method and apparatus for personal screening for early signs of cervical cancer is claimed, whereby the user performs daily or almost daily a diagnostic self-check for some other aspect of reproductive health, and the electronic testing for cervical cancer type of tissue aberration is performed automatically in the background. The screening is invisible to the user, causing no anxiety and no discomfort. The user only becomes alerted to the need to see a physician if a preset condition of reproducibility is reached in the background evaluation of the measurement data if the aberrant pattern has been detected consecutively in a preset number of menstrual cycles, the device prompts the woman to see a physician with a view to undergoing a more demanding definitive diagnostic examination such as colposcopy with biopsy. The invention provides the diagnostic screen in a manner that does not cause the discomfort, anguish and anxiety associated with the Pap smear screen of the prior art.

The invention discloses a medicine for treating the irregular menstrual period and a preparation method thereof. The medicine is prepared from angelica sinensis, cinnamon, rhizoma cyperi, turmeric, red flower, hematoxylon, sunflower, codonopsis pilosula and moutan bark according to a certain weight proportion. The medicine has the effects of nourishing yin, clearing the heat, promoting qi to activate blood, dissipating blood stasis to stop pain, tonifying kidneys, stopping bleeding and adjusting the menstrual period, has a quick response of treating the irregular menstrual period and is short in treatment period.

A method of birth control and hormone regulation comprises utilizing a vaginal ring worn continuously during each menstrual cycle. A vaginal ring delivers predetermined doses of progesterone and beta-estradiol. Beta-estradiol does not cause an increase in sex hormone binding globulin and thereby does not decrease a woman's levels of free testosterone and libido.